Placebo-Controlled Trials, Ethics, and the Goals of Comparative Effectiveness Research

被引:7
作者
Pearson, Steven D. [1 ]
机构
[1] Inst Clin & Econ Review, Boston, MA 02114 USA
关键词
D O I
10.1001/archinternmed.2011.1715
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:244 / 245
页数:3
相关论文
共 50 条
[31]   The ethics of placebo-controlled trials for perinatal transmission of HIV in developing countries [J].
Clark, PA .
JOURNAL OF CLINICAL ETHICS, 1998, 9 (02) :156-166
[32]   THE ETHICS OF PLACEBO-CONTROLLED TRIALS IN SCHIZOPHRENIA: A VIEW INFORMED BY WORKING WITH INDUSTRY [J].
Conley, Robert R. .
SCHIZOPHRENIA RESEARCH, 2014, 153 :S14-S15
[33]   What is controlled for in placebo-controlled trials? [J].
Fillingim, RB ;
Price, DD .
MAYO CLINIC PROCEEDINGS, 2005, 80 (09) :1119-1121
[34]   Randomized Controlled Trials and Comparative Effectiveness Research [J].
Hahn, Olwen M. ;
Schilsky, Richard L. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34) :4194-4201
[35]   Alternatives to placebo-controlled trials [J].
Streiner, David L. .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2007, 34 :S37-S41
[36]   Blinding in placebo-controlled trials [J].
Prasad, AS .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (12) :1150-1150
[37]   Building in placebo-controlled trials [J].
Ehrlich, GE .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (12) :1150-1151
[38]   MOCLOBEMIDE - PLACEBO-CONTROLLED TRIALS [J].
SILVERSTONE, T .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1993, 7 (3-4) :133-136
[39]   Placebo-controlled trials - Response [J].
Temple, R ;
Ellenberg, SS .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (01) :63-64
[40]   Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research [J].
McMahon, Robert P. ;
Kelly, Deanna L. ;
Boggs, Douglas L. ;
Li, Lan ;
Hu, Qiaoyan ;
Davis, John M. ;
Carpenter, William T., Jr. .
SCHIZOPHRENIA BULLETIN, 2008, 34 (02) :292-301